Roche launches innovative dual antigen and antibody diagnostic test supporting the fight to eliminate the hepatitis C virus
Elecsys HCV Duo is the first commercially misogynist immunoassay that allows the simultaneous and self-sustaining determination of the hepatitis C virus (HCV) antigen and pathogen status.The Elecsys HCV Duo immunoassay